ArticleFrontiers in oncology2024
Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden.
Rebekka Mispelbaum et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it